Protalix BioTherapeutics, Inc. — Institutional Ownership

Which tracked institutions hold PLX, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.

18
Funds holding
$16921198
Total value held
Buying
13 added/new · 3 reduced
# Institution Value Shares Δ Shares Change (QoQ)
1 Blackrock, Inc. $9428694 4046650 +429688 +11.88%
2 State Street Corp $2291746 983582 +10767 +1.11%
3 Northern Trust Corp $2149053 922340 +36892 +4.17%
4 Goldman Sachs Group Inc $1108899 475922 +224577 +89.35%
5 Bank Of New York Mellon Corp $542871 232992 +13685 +6.24%
6 Ubs Group Ag $323045 138646 +138646 NEW BUY
7 Jpmorgan Chase & Co $312529 132991 +101306 +319.73%
8 Wells Fargo & Company/Mn $157389 67549 +41027 +154.69%
9 Bank Of America Corp /De/ $120918 51896 -27183 -34.37%
10 Morgan Stanley $120405 51676 -250117 -82.88%
11 Franklin Resources Inc $96262 41314 +41314 NEW BUY
12 Invesco Ltd. $85548 36716 +36716 NEW BUY
13 Citigroup Inc $80825 34689 +33055 +2022.95%
14 Equitable Holdings, Inc. $30640 13150 +2000 +17.94%
15 Barclays Plc $26771 11490 -3332 -22.48%
16 Prudential Financial Inc $23556 10110 Held
17 Royal Bank Of Canada $22000 9654 +2086 +27.56%
18 Pnc Financial Services Group, Inc. $47 20 Held

Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.